Quest Diagnostics Inc banner

Quest Diagnostics Inc
F:QDI

Watchlist Manager
Quest Diagnostics Inc Logo
Quest Diagnostics Inc
F:QDI
Watchlist
Price: 178.4 EUR 0.34% Market Closed
Market Cap: €19.9B

Wall St Price Targets

QDI Price Targets Summary
Quest Diagnostics Inc

Wall Street analysts forecast QDI stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for QDI is 177.64 EUR with a low forecast of 142.08 EUR and a high forecast of 201.91 EUR.

Lowest Forecast
Price Target
142.08 EUR
20% Downside
Average Forecast
Price Target
177.64 EUR
0% Downside
Highest Forecast
Price Target
201.91 EUR
13% Upside
Quest Diagnostics Inc Competitors:
Price Targets
OGI
OrganiGram Holdings Inc
114% Upside
SMMT
Summit Therapeutics Inc
104% Upside

Revenue
Forecast

3% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
3% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 6%.

Gross Profit
Forecast

1% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
1% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 3 years is 6%.

Operating Income
Forecast

2% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
2% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 9%.

Pre-Tax Income
Forecast

2% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
2% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 2%. The projected CAGR for the next 3 years is 14%.

Net Income
Forecast

5% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
5% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 3 years is 13%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is QDI's stock price target?
Price Target
177.64 EUR

According to Wall Street analysts, the average 1-year price target for QDI is 177.64 EUR with a low forecast of 142.08 EUR and a high forecast of 201.91 EUR.

What is the Revenue forecast for Quest Diagnostics Inc?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 6%.

What is the Gross Profit forecast for Quest Diagnostics Inc?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 3 years is 6%.

What is the Operating Income forecast for Quest Diagnostics Inc?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 9%.

What is the Pre-Tax Income forecast for Quest Diagnostics Inc?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 2%. The projected CAGR for the next 3 years is 14%.

What is the Net Income forecast for Quest Diagnostics Inc?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 3 years is 13%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett